{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-105541","form_type":"8-K","ticker":"IOBTQ","cik":"0001865494","company_name":"IO Biotech, Inc.","filed_at":"2022-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.936891+00:00","generated_at":"2026-06-26T07:28:26.862001+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Two IO Biotech directors to step down at 2022 annual meeting","bullets":["Dr. Claus Andersson and Dr. Emmanuelle Coutanceau notified the Board they will not stand for reelection.","Effective at the Company's 2022 annual meeting of stockholders.","Decisions are not due to any disagreement with the Company or Board regarding operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-105541","json":"https://secwatch.observer/filing/0001193125-22-105541.json","markdown":"https://secwatch.observer/filing/0001193125-22-105541.md","text":"https://secwatch.observer/filing/0001193125-22-105541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/d299788d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:28:26.862001+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17f860e31d","claim":"Claus Andersson departed as Director at IO Biotech, Inc..","evidence_excerpt":"On April 12, 2022, Dr. Claus Andersson, a director of the board of directors (the “Board”) of the IO Biotech, Inc. (the “Company”), notified the Company that he will not stand for reelection at the Company’s 2022 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"94d09029df","claim":"Emmanuelle Coutanceau departed as Director at IO Biotech, Inc..","evidence_excerpt":"On the same date, Dr. Emmanuelle Coutanceau, a director of the Board, notified the Company that she will not stand for reelection at the Company’s 2022 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}